Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Synthesis

Steps To St. John's Wort Factor

Diels-Alder reaction anchors synthesis of ent-hyperforin, enantiomer of key component in St. John's wort

by Carmen Drahl
January 25, 2010 | A version of this story appeared in Volume 88, Issue 4

Combining a Diels-Alder reaction with strategic rearrangements, chemists at the University of Tokyo have completed the first total synthesis of the nonnatural enantiomer of hyperforin, a complex plant natural product first reported nearly 40 years ago (Angew. Chem. Int. Ed., DOI: 10.1002/anie.200906678). Hyperforin is thought to be an active ingredient in St. John’s wort, a traditional but as-yet-unproven herbal remedy for depression that can dampen the effectiveness of several prescription drugs. Although related natural products have succumbed to total synthesis, hyperforin has remained a challenge. Now, Masakatsu Shibasaki and colleagues have worked out a route to ent-hyperforin centered on an iron-catalyzed asymmetric Diels-Alder reaction they previously developed (Org. Lett. 2004, 6, 4387). After using that reaction to set up two contiguous stereocenters, the team turned to a stereoselective Claisen rearrangement to fashion an adjacent quaternary center. An aldol reaction stitched the molecule’s bicyclic core together, and a vinylogous Pummerer rearrangement installed the last of the molecule’s oxygen-containing moieties. The team is working to make hyperforin via the enantiomer of their Diels-Alder catalyst, Shibasaki says.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.